Company Filing History:
Years Active: 2014
Title: The Innovative Journey of Jean-Marc Renaud: A Pioneer in Smoking Article Technology
Introduction: Jean-Marc Renaud, an inventive mind based in Peseux, Switzerland, has made significant strides in the field of smoking technology. With one patent to his name, he contributes to the ever-evolving landscape of aerosol-generating substrates used in smoking articles. His work is vital for enhancing tobacco products while addressing societal health concerns.
Latest Patents: Renaud's notable patent, titled "Aerosol-generating substrate for smoking articles," introduces a groundbreaking concept. The invention comprises strands of homogenized tobacco material that include at least one aerosol former. This substrate allows manufacturers to improve the efficiency and safety of smoking articles. The strands are designed to possess a mass-to-surface-area ratio of at least about 0.09 mg/mm, with an aerosol former content ranging between 12% and 25% by weight, reflecting advanced engineering in tobacco product design.
Career Highlights: Currently, Renaud works with Philip Morris USA Inc., a company known for its focus on innovating tobacco products. His role within the organization allows him to explore new avenues in the smoking industry, contributing to product development and innovation that aims to meet consumer needs and regulatory challenges.
Collaborations: Throughout his career, Renaud has collaborated with esteemed colleagues like Jean-Jacques Pladé and Jacques Armand Zuber. These partnerships foster an environment conducive to innovation, enabling them to combine their expertise and insights into creating advanced solutions in smoking technology.
Conclusion: Jean-Marc Renaud stands out as a prominent inventor in the realm of aerosol-generating substrates for smoking articles. His contributions reflect a commitment to innovation and research in the tobacco industry. With a strong patent portfolio and collaborative efforts, Renaud continues to push the boundaries of his field, ensuring that new developments align with health standards and consumer expectations.